Biographies

Mr. Shlomo Shalev Spokone has been appointed Interim Chairman of the Board at X T L Biopharmaceuticals Ltd. effective August 31, 2015. Until this date, he served as Director at the Company since December 2014. His work experience includes the following roles: Chairman of the Board of Micronet, Board Member at OphirOptronics, Arel Communications and PowerDsine, Senior Vice President of Investments at Ampal and Israel’s Consul for Economic Affairs and the Economic Advisor to the Director General, Ministry of Industry and Trade. He holds a Bachelors degree in Economics from Ben Gurion University and a MBA degree from University of San Francisco.

Dr. Daphna Paran has been appointed Medical Director at X T L Biopharmaceuticals Ltd. effective March 9, 2016. Dr. Paran has over 20 years of rheumatology expertise with a focus on lupus. She is a senior lecturer at Tel Aviv University, the head of the lupus clinic, head of the rheumatology day care unit and the deputy head of the Department of Rheumatology at the Tel Aviv Medical Center (Ichilov Hospital). She completed her medical studies at Ben Gurion University, trained in lupus and the antiphospholipid syndrome at the lupus unit, Rayne Institute, St. Thomas' Hospital in London and has published or co-authored over 60 articles in the field of lupus and rheumatology.

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: